NDC 63083-4004

Vaccinosis Nosode 4004

Vaccinosis Nosode

Vaccinosis Nosode 4004 is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Professional Complementary Health Formulas. The primary component is Anguilla Rostrata Blood Serum; Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated); Diphenyltrichloroethane; Laurtrimonium Bromide; Mumps Virus; Oyster Shell Calcium Carbonate, Crude; Serum, Horse; Silicon Dioxide; Thuja Occidentalis Leaf.

Product ID63083-4004_a852befd-5afb-4861-a18c-ae4f62405da4
NDC63083-4004
Product TypeHuman Otc Drug
Proprietary NameVaccinosis Nosode 4004
Generic NameVaccinosis Nosode
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date1984-08-15
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameProfessional Complementary Health Formulas
Substance NameANGUILLA ROSTRATA BLOOD SERUM; CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); DIPHENYLTRICHLOROETHANE; LAURTRIMONIUM BROMIDE; MUMPS VIRUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SERUM, HORSE; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAF
Active Ingredient Strength30 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
Pharm ClassesActively Acquired Immunity [PE], Inactivated Clostridium Tetani Vaccine [EPC], Tetanus Toxoid [CS], Vaccines, Inactivated [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 63083-4004-2

59 mL in 1 BOTTLE, DROPPER (63083-4004-2)
Marketing Start Date1985-08-15
NDC Exclude FlagN
Sample Package?N

Drug Details

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.